Property, Plant and Equipment

12 Months Ended

Dec. 31, 2013

Property, Plant and Equipment [Abstract]

NOTE 5 Property, Plant and Equipment



(In thousands)	2013			2012
Machinery and equipment	$	1,937,914		$	1,866,263
Buildings and improvements	304,971			299,642
Land improvements	54,277			52,929
Office and other equipment	11,951			10,946
Land	11,827			11,827
Construction in progress	40,204			37,160
	$	2,361,144		$	2,278,767
Less accumulated depreciation and amortization	(1,476,446		)	(1,401,390		)
	$	884,698		$	877,377

The December 31, 2013 and 2012 buildings and improvements and machinery and equipment combined balances each include $23.1 million associated with capital leases.

Depreciation expense, including amounts associated with capital leases, totaled $83.3 million, $74.6 million and $70.6 million in 2013, 2012 and 2011, respectively. We did not capitalize any interest during 2013. For 2012 and 2011, we capitalized $12.6 million and $3.7 million of interest expense, respectively, associated with our TAD tissue expansion project, which includes the construction of our new tissue manufacturing and converting facilities in Shelby, North Carolina, and upgrades to our tissue manufacturing facility in Las Vegas, Nevada.

- Definition

The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.

+ References+ Details